Shandong, China

Gao Li

This inventor holds 1 USPTO granted patent. Top assignee: Qilu Pharmaceutical Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gao Li. Retrieved from https://idiyas.com/inventor/gao-li-igiu0dze

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Gao Li

Gao Li is a prominent inventor based in Shandong, China. He has made significant contributions to the field of biotechnology, particularly in cancer treatment. His work focuses on developing innovative solutions that can improve patient outcomes.

Latest Patents

Gao Li holds a patent for an "Antibody against claudin 18A2 and use thereof." This patent includes an anti-CLDN18.2 antibody or an antigen-binding fragment thereof, along with a derivative comprising said antibody or antigen-binding fragment. The pharmaceutical composition and related uses of this antibody are aimed at treating, diagnosing, and detecting cancers. Gao Li has 1 patent to his name.

Career Highlights

Gao Li is associated with Qilu Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. His work at this organization has allowed him to contribute to groundbreaking research and development in cancer therapies. His expertise in antibody development has positioned him as a key figure in the fight against cancer.

Collaborations

Gao Li collaborates with talented individuals such as Yingying Yang and Yaning Wang. These partnerships enhance the research and development efforts within his team, leading to innovative solutions in the medical field.

Conclusion

Gao Li's contributions to biotechnology and cancer treatment through his patent and work at Qilu Pharmaceutical Co., Ltd. highlight his importance as an inventor. His innovative approaches continue to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…